EDGAR Filing Documents for 0001193125-21-067801

Form 8-K - Current report:

SEC Accession No. 0001193125-21-067801

Filing Date

2021-03-03

Accepted

2021-03-03 17:10:53

Documents

Period of Report

2021-03-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d108939d8k.htm	8-K	21927
2	EX-1.1	d108939dex11.htm	EX-1.1	179281
3	EX-5.1	d108939dex51.htm	EX-5.1	7608
4	EX-99.1	d108939dex991.htm	EX-99.1	6813
5	EX-99.2	d108939dex992.htm	EX-99.2	6801
6	GRAPHIC	g108939g0303233704451.jpg	GRAPHIC	2642
7	GRAPHIC	g108939g0304010027560.jpg	GRAPHIC	631
	Complete submission text file	0001193125-21-067801.txt		228390

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110

Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244

Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 21710339
SIC: 2834 Pharmaceutical Preparations